Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  MetLife    MET

METLIFE (MET)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

MetLife : Japan Awards Three New Tech Contracts Through collab 2.0

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/08/2017 | 12:23pm CET

Moneytree, Montoux and WorkFusion beat 111 competitors from 24 countries for a JPY10 million contract

LumenLab, MetLife Asia’s Singapore-based innovation center, today announced the winners of collab 2.0, an open innovation platform designed to match startups with business opportunities within MetLife Japan.

The winners - Moneytree, Montoux and WorkFusion competed with 111 applicants from 24 countries around the world to each win a JPY 10 million contract to work on a project with MetLife Japan.

“We are delighted by the continued enthusiasm for collab 2.0 across the global startup community,” said Zia Zaman, LumenLab CEO and Chief Innovation Officer of MetLife Asia.

Moneytree, Montoux and WorkFusion represent the best in creativity and innovation, bringing fresh thinking to address the evolving needs of our customers. We’re excited to see their solutions implemented and to see what will come from many other startup relationships established through collab 2.0.”

Collab 2.0, launched in August and aims to give innovators a platform to address business challenges in areas like customer engagement, sales, and operations.

Following a rigorous review process, six finalists - Concierge U, Gnowbe, Moneytree, Montoux, TrustSphere, and WorkFusion - were selected and paired with MetLife employees to help them further hone their ideas.

The six finalists were invited to Tokyo this week to attend the collab Summit Japan, which drew industry experts from across Asia and world-class insurtech entrepreneurs. The program culminated in a Demo Day where the finalists pitched their ideas to a judging panel of senior MetLife and LumenLab executives.

The finalist pitches showcased an exciting mix of ideas and technological solutions ranging from artificial intelligence (AI) and predictive analytics, to robotics process automation (RPA).

“For the past 150 years, MetLife has been at the forefront of innovation. Thanks to LumenLab’s collab 2.0, we are continuing that tradition by connecting with cutting-edge startups from around the globe to develop new solutions that help people lead healthier and more fulfilled lives,” said Sachin N. Shah, President and CEO, MetLife Japan.

For more information on collab 2.0 and the finalists, visit http://collab.lumenlab.sg/#finalists.

* Equates to approximately US$91,000 based on the FX rate of 1USD:JPY109.89 as of 4 August 2017

About MetLife

MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help its individual and institutional customers navigate their changing world. Founded in 1868, MetLife has operations in more than 40 countries and holds leading market positions in the United States, Japan, Latin America, Asia, Europe and the Middle East. For more information, visit www.metlife.com.

About MetLife Japan

MetLife started operations in 1973 as the first foreign life insurance company in Japan. Since then, it has provided an innovative and broad range of products through diverse distribution channels to individual and institutional customers. It currently operates as a Japanese corporation, MetLife Insurance K.K. MetLife is committed to providing trusted navigation to help people become more self-reliant and able to pursue more from life. For more information, visit http://www.metlife.co.jp/

About LumenLab

As MetLife's pioneers for disruptive innovation, LumenLab is charging ahead to create new businesses in health, wealth and retirement. Lumen, a measure of light, symbolizes our commitment to illuminating a new path for solving the problems that the people of Asia face today. Through our focus on building new products and services grounded in technology and data, we aim to help people achieve richer and more fulfilling lives. For more information, visit www.lumenlab.sg


© Business Wire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on METLIFE
12/08 METLIFE : Japan Awards Three New Tech Contracts Through collab 2.0
12/04 METLIFE HONG KONG : Sponsors Pink Heels Race 2017 to Support Awareness of Heredi..
11/30 EMPLOYEES TO EMPLOYERS : We Want You to Share Our Values, Make World Better Plac..
11/29DJWells Fargo Adds Three Board Members as Regulators Weigh Action
11/29 EMPLOYEES TO EMPLOYERS : We Want You to Share Our Values and Make the World a Be..
11/22 METLIFE HONG KONG : Sponsors Diabetes Management Activities
11/21 Big insurers welcome regulators' rethink of sector risks
11/20 METLIFE INC : Other Events, Financial Statements and Exhibits (form 8-K)
11/17DJMETLIFE : Treasury Calls for Overhaul of Systemically Important Designation -- 4..
11/17DJMETLIFE : Treasury Calls for Overhaul of Systemically Important Designation -- 3..
More news
News from SeekingAlpha
12/09 Stocks to watch next week
12/09 STOCKS TO WATCH : Investors Eye 2018 Picks
12/05 Buy Prudential Financial For Income
12/04 Oppenheimer Financials Sector Revenue ETF (RWW) November Summary
12/04 35 Stocks For December 2017
Financials ($)
Sales 2017 64 306 M
EBIT 2017 6 157 M
Net income 2017 3 310 M
Debt 2017 -
Yield 2017 3,00%
P/E ratio 2017 16,37
P/E ratio 2018 11,38
Capi. / Sales 2017 0,88x
Capi. / Sales 2018 0,88x
Capitalization 56 572 M
Chart METLIFE
Duration : Period :
MetLife Technical Analysis Chart | MET | US59156R1086 | 4-Traders
Technical analysis trends METLIFE
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 56,3 $
Spread / Average Target 4,8%
EPS Revisions
Managers
NameTitle
Steven Albert Kandarian Chairman, President & Chief Executive Officer
Martin J. Lippert Executive VP-Global Technology & Operations
John C. R. Hele Chief Financial Officer & Executive Vice President
Jacki Goldstein Chief Medical Officer
Cheryl W. Grisé Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
METLIFE-0.50%56 572
AXA5.36%72 742
PRUDENTIAL11.24%63 542
PRUDENTIAL FINANCIAL INC11.00%50 418
MANULIFE FINANCIAL CORP.10.81%41 443
AFLAC INCORPORATED26.35%34 660